Credit Suisse analyst Jailendra Singh reiterated an Outperform rating and $136 price target on eHealth following the company's presentation at a healthcare investor conference, saying he feels "good" about the company's trends. In a research note to investors, Singh says eHealth believes the deployment of various tools and technologies to power the decision to support tools for its agents could yield upside to the company's 2019 guidance, and says eHealth should also benefit from having more tenured agents. Additionally, the analyst notes that eHealth is also optimistic that the new third party vendors it has partnered with will drive its conversion rate even higher in the fourth quarter.